
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title xml:lang="srp">Процена адекватности прописивања терапије код старих особа са кардиоваскуларним болестима</dc:title>
  <dc:creator>Stojanović,  Goran, 1963-, 74697993</dc:creator>
  <dc:description xml:lang="srp">Cilj: Istraživanje koje je vršeno imalo je za cilj da odredi prevalencu PIM-a u 
populaciji starih ispitanika koji su imali dijagnostikovano kardiovaskularno
oboljenje i da kvantifikuje značaj određenih varijabli na prisustvo PIM-a.
Metoda: Sprovedena je hibridna studija koja je u prvom delu, od početka 2016. godine 
do kraja 2017.godine izvedena kao studija preseka (periodična prevalencija), a u 
drugom delu, tokom 2018. godine, kao klinička studija sa intervencijom putem 
edukacije, sa poređenjem pre i posle intervencije. Studijski uzorak obuhvatao je 1500 
pacijenata starijih od 65 godina sa kardiovaskularnim oboljenjima a da su bili 
korisnici zdravstvenih usluga i imali dostupnu medicinsku dokumentaciju u Zavodu
za gerijatriju i palijativno zbrinjavanje u Beogradu. Intervencijski deo istraživanja 
vršen je sa lekarima koji sprovode zdravstvenu zaštitu starih osoba a samim tim i 
propisivanje medikamentozne terapije čija adekvatnost propisivanja je analizirana 
upotrebom standardnih međunarodnih kriterijumima, American Geriatrics Society 2015 
updated Beers Criteria for potentially inappropriate medication use in older adults.
Potrošnja lekova u navedenoj ustanovi za posmatrane periode je vršena prema 
utvrđenoj ATC/DDD metodologiji koja je definisana od strane ekperata SZO.
Rezultati: Učestalost PIM-a u ispitivanoj populaciji iznosila je 70,3% za period 
2016.-2017. godine i 71,3% u toku 2018. godine. Posmatrano u odnosu na pol, 
ispitanice ženskog pola su bile dominatnije u grupi sa PIM-om. Najviše
ispitanika imalo je 4 komorbiditeta uz osnovnu dijagnozu. Komorbiditeti sa visokom 
frekvencom su bili u grupi bolesti I00-I99 (bolesti srca i krvnih sudova) (36.9%). 
Dijagnoze koje su najviše zabeležene su bile iz podgrupe I10- I15 (hipertenzivne 
bolesti) (48,83%), I20-I25 (ishemijske bolesti srca) (20,38%). Po pacijentu je u 
periodu 2016-2017 godine propisivano 7,2 leka dok je tokom 2018. godine iznosio 7,3. 
Lekovi koji su potencijalno neadekvatno propisivani sa najvećom frekvencom su: 
benzodiazepini srednjeg delovanja (79,03%), centralni α blokatori (23,57%), 
antipsihotici (tipični i atipični) (30,75%). Potencijalno klinički značajne 
neinfektivne interakcije lek-lek koje bi trebalo izbegavati kod starih osoba beleži 
pad sa (35,5% na 30,9%) u prospektivnom periodu. Potencijalno neadekvatno 
propisivanje lekova koji se moraju koristiti sa oprezom kod starih osoba beleži 
smanjenje za: antipsihotike (29,5% na 27,8%), diuretike (69,9% na 63,8%) i SSRI 
(22,7% na 19,7%). Potencijalno neadekvatno propisivanje lekova usled lek-bolest ili 
lek-sindrom interakcije koje mogu pogoršati bolest ili sindrom zabeleženo je u 
periodu 2016.-2017. u 105 slučajeva ili (8,6%) a nakon intervencije 2018.godine u 74 
slučajeva odnosno (6,4%) Prediktori za PIM su brojni i to: polifarmacija, pol, 
upotreba nikotina, kognitivni status, uhranjenost i komorbiditet za period pre 
intervencije a nakon toga je pokazan i uticaj bračnog stanja i emocionalnog statusa.
Zaključak: Kardiovaskularne bolesti u starijoj populaciji povezane su sa visokom 
prevalencijom potencijalno neadekvatnog propisivanja lekova. Iako je zabeleženo 
smanjenje potrošnje pojedinih kardiovaskualrnih lekova nakon održane edukacije, 
prevalenca PIM-a nije se smanjila. Kreiranje zdravstvenih preporuka za propisivanje 
lekova kod starijih osoba koje bi naglasile navedene faktore moglo bi uticati na 
smanjenje prevalencije PIM-a u navedenoj popilaciji.</dc:description>
  <dc:description xml:lang="eng">Aim: Study has purpose to show prevalence of PIM in the population of elderly person with the cardiovascular disease and to quantify influence of the specific variable on PIM presence. 
Methods: A hybrid study was performed, which in the first part, from the beginning of 2016 to the end of 2017, was performed as a cross-sectional study (periodic prevalence), and in the second part, during 2018, as a clinical study with interventions during education and after interventions. Sample of the study inluded 1500 partcipants older then 65 years with cardiovascular disease and who was used specific health services and had medical data at the Institute for Gerontology and Palliative Care, Belgrade. Interventional part of the study was 
done with medical doctor who presribed drugs at this institution. The adequacy of the prescribed therapy was assessed by American Geriatrics Society 2015 updated Beers Criteria 
for potentially inappropriate medication use in older adults. Drug consumption for the 
observed periods was determinated by established ATC/DDD methodology defined by WHO 
experts.
Results: PIM frequency in the examined population was 70,3% during the period 2016-2017 
and 71,3% during the 2018. Observed in relation to gender, female respondents were more 
dominant in the group with PIM. Most subjects had 4 comorbidities with a basic diagnosis.
Comorbidities with high frequency were in the group of diseases I00-I99 (cardiovascular 
diseases) (36.9%). The most frequently diagnosed diagnoses were from subgroup I10-I15 
(hypertensive diseases) (48.83%), I20-I25 (ischemic heart diseases) (20.38%). In the period 
2016-2017, 7.2 drugs were prescribed per patient, while in 2018 it was 7.3. Drugs that are 
potentially inadequately prescribed with the highest frequency are: medium-acting 
benzodiazepines (79.03%), central α blockers (23.57%), antipsychotics (typical and atypical) 
(30.75%). Potentially clinically significant non-infectious drug-drug interactions that should 
be avoided in the elderly decreased from 35.5% to 30.9% in the prospective period.
Potentially inadequate prescribing of drugs that must be used with caution in the elderly 
decreased for: antipsychotics (29.5% to 27.8%), diuretics (69.9% to 63.8%) and SSRIs 
(22.7% to 19.7%). Potentially inadequate drug prescribing due to drug-disease or drugsyndrome interactions that may exacerbate the disease or syndrome was noted in the period 
2016-2017. in 105 cases or (8.6%) and after the intervention in 2018 in 74 cases or (6.4%) 
Predictors for PIM are numerous, as follows: polypharmacy, sex, nicotine use, cognitive 
status, nutrition and comorbidity for the period before interventions and after that the 
influence of marital status and emotional status is shown.
Conclusion: Cardiovascular diseases in the elderly population are associated with a high 
prevalence of potentially inadequate drug prescribing. Although a decrease in the 
consumption of certain cardiovascular drugs was observed after the training, the prevalence of 
PIM did not decrease. Creating health recommendations for prescribing drugs in the elderly 
that would emphasize these factors could reduce the prevalence of PIM in this population.</dc:description>
  <dc:description xml:lang="srp"></dc:description>
  <dc:contributor>Milovanović,  Olivera, 1986-, 6456679</dc:contributor>
  <dc:contributor>Đurić,  Dušan, 1960-, 11652711</dc:contributor>
  <dc:contributor>Folić,  Marko, 1979-, 13593447</dc:contributor>
  <dc:contributor>Marković-Denić,  Ljiljana, 1956-, 12460135</dc:contributor>
  <dc:date>2021</dc:date>
  <dc:date>2021</dc:date>
  <dc:date>2021</dc:date>
  <dc:date>2021</dc:date>
  <dc:date>2021</dc:date>
  <dc:date>2021</dc:date>
  <dc:type xml:lang="eng">baccalaureate Dissertation</dc:type>
  <dc:format>191 list</dc:format>
  <dc:format>4897492 bytes</dc:format>
  <dc:identifier>o:1399</dc:identifier>
  <dc:identifier>ID=47749385 ; D-3450</dc:identifier>
  <dc:identifier>thesis:8328</dc:identifier>
  <dc:identifier>cobiss:47749385</dc:identifier>
  <dc:identifier>https://phaidrakg.kg.ac.rs/o:1399</dc:identifier>
  <dc:source>Thesis:8328</dc:source>
  <dc:source>Cobiss:47749385</dc:source>
  <dc:language>srp</dc:language>
  <dc:rights>CC BY 2.0 AT</dc:rights>
  <dc:rights>http://creativecommons.org/licenses/by/2.0/at/</dc:rights>
</oai_dc:dc>
